InsidersTradesSigma
Browse the full record of transactions filed by Jones Kristi, Chairman & CEO. Officer active across 1 companies, notably NexImmune, Inc.. Cumulatively, 1 filings have been published. Total volume traded: €34k. The latest transaction was filed on 29 March 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Jones Kristi is the President and CEO of NexImmune, Inc. She leads the company in developing innovative immunotherapy solutions. Her experience and strategic vision are crucial for advancing research and development projects.